Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Non Operating Income (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Non Operating Income for 9 consecutive years, with $4.8 million as the latest value for Q1 2026.

  • For Q1 2026, Non Operating Income fell 42.26% year-over-year to $4.8 million; the TTM value through Mar 2026 reached $24.7 million, down 37.62%, while the annual FY2025 figure was $28.3 million, 21.67% down from the prior year.
  • Non Operating Income hit $4.8 million in Q1 2026 for Bicycle Therapeutics, down from $5.8 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $14.7 million in Q4 2024 and bottomed at -$600000.0 in Q1 2022.
  • Average Non Operating Income over 5 years is $4.8 million, with a median of $4.8 million recorded in 2026.
  • Year-over-year, Non Operating Income crashed 136.0% in 2023 and then skyrocketed 77322.22% in 2024.
  • Bicycle Therapeutics' Non Operating Income stood at $1.8 million in 2022, then skyrocketed by 200.94% to $5.5 million in 2023, then soared by 169.92% to $14.7 million in 2024, then plummeted by 60.49% to $5.8 million in 2025, then fell by 17.01% to $4.8 million in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $4.8 million, $5.8 million, and $6.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.